Table 2 Outcome comparison, period I vs. period II+III
From: Prognostic effects of treatment protocols for febrile convulsive status epilepticus in children
| Â | Period I n=26 | Period II+III n=84 | Risk difference (95% CI) | p-value |
|---|---|---|---|---|
PCPC scale score ≥2, n (%) | 6 (23.1) | 6 (7.1) | -16.0% (-30.0% to -1.8%) | 0.03 |
Final diagnosis | ||||
 AE, n (%) | 9 (34.6) | 11 (13.1) | -21.5% (-39.5% to -3.9%) | 0.02 |
  AESD, n (%) | 5 (19.2) | 6 (7.1) | -12.1% (-26.0% to 0.8%) | 0.12 |
  MERS, n (%) | 0 (0) | 1 (1.2) | 1.2% (-2.8% to 1.2%) | 1 |
  Unclassified AE, n (%) | 4 (15.4) | 4 (4.8) | -10.6% (-21.8% to 0.6%) | 0.09 |
  Febrile seizure, n (%) | 17 (65.4) | 73 (86.9) | 21.5% (3.9% to 39.5%) | 0.02 |
Treatment-related complication | ||||
 VAP, n (%) | 0 (0) | 7 (8.3) | 8.3% (-3.5% to 8.3%) | 0.20 |